Medicine & Life Sciences
Urinary Bladder Neoplasms
100%
Apoptosis
53%
Neoplasms
33%
Bortezomib
26%
Proteasome Inhibitors
20%
DNA Fragmentation
19%
Thymocytes
19%
Pancreatic Neoplasms
18%
Cell Line
16%
Cell Death
15%
Drug Therapy
14%
Carcinoma
13%
ErbB Receptors
13%
Urinary Bladder
13%
gemcitabine
12%
Muscles
12%
Endonucleases
12%
Neoplasm Metastasis
11%
Therapeutics
11%
Cisplatin
10%
Bacillus
9%
Survival
9%
Glucocorticoids
9%
Biomarkers
8%
Growth
8%
Heterografts
8%
Interferons
8%
T-Cell Antigen Receptor
7%
Histone Deacetylase Inhibitors
7%
orantinib
7%
Clinical Trials
7%
Epithelial-Mesenchymal Transition
7%
Signal Transduction
7%
Proteins
7%
B-Cell Chronic Lymphocytic Leukemia
7%
marizomib
6%
Melanoma
6%
Calcium
6%
Gefitinib
6%
Vascular Endothelial Growth Factor A
6%
Proteasome Endopeptidase Complex
6%
Endothelial Cells
6%
Adenocarcinoma
6%
T-Lymphocytes
6%
Caspases
6%
Mutation
6%
Protein-Tyrosine Kinases
5%
Phosphorylation
5%
Cystectomy
5%
Prostatic Neoplasms
5%